ASSOCIATION BETWEEN MOLECULAR SUBTYPES OF COLORECTAL TUMORS AND PATIENT SURVIVAL, BASED ON POOLED ANALYSIS OF 7 INTERNATIONAL STUDIES
Current clinical practice includes testing for microsatellite instability (MSI) status, KRAS mutation status, and/or BRAF mutation status in a subset of patients with colorectal cancer (CRC) based on reported family history and stage at diagnosis. Patients with type 2 CRC had the poorest prognosis, particularly with respect to disease-specific survival (DSS). Regardless of other tumor […]
